Загрузка...
Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial)
BACKGROUND: With the availability of infliximab, nowadays recurrent Crohn's disease, defined as disease refractory to immunomodulatory agents that has been treated with steroids, is generally treated with infliximab. Infliximab is an effective but expensive treatment and once started it is uncl...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
BioMed Central
2008
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2533646/ https://ncbi.nlm.nih.gov/pubmed/18721465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2482-8-15 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|